J&J Wins First Tylenol Liver Damage Trial
Johnson & Johnson and its subsidiary McNeil Consumer Healthcare on Friday won the first trial over the alleged liver damage risks of McNeil's Extra Strength Tylenol when a New Jersey state...To view the full article, register now.
Already a subscriber? Click here to view full article